Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Repligen Corp RGEN

Technology Scientific & Technical Instruments
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; process analytics, and proteins. Its filtration products are used in process development and process scale (clinical and commercial... see more

Recent & Breaking News (NDAQ:RGEN)

Repligen Corporation Announces Closing of Public Offerings of $138.1 Million of Common Stock and $287.5 Million of 0.375% Convertible Senior Notes due 2024, Including Full Exercise of Underwriters' Options

GlobeNewswire July 19, 2019

Repligen Corporation Announces Pricing of Public Offerings of $120 million of Common Stock and $250 million of 0.375% Convertible Senior Notes due 2024

GlobeNewswire July 17, 2019

Repligen Corporation Announces Proposed Public Offerings of $100 million of Common Stock and $250 million of Convertible Senior Notes

GlobeNewswire July 15, 2019

Repligen to Present at Jefferies 2019 Healthcare Conference

GlobeNewswire June 4, 2019

Repligen Reports First Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance

GlobeNewswire May 9, 2019

Repligen to Report First Quarter 2019 Financial Results

GlobeNewswire May 2, 2019

Repligen Corporation Prices Public Offering of Shares of Common Stock

GlobeNewswire April 30, 2019

Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock

GlobeNewswire April 29, 2019

Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator C Technologies and Reports Preliminary First Quarter 2019 Financial Results

GlobeNewswire April 26, 2019

Repligen Reports Fourth Quarter and Full Year 2018 Financial Results

GlobeNewswire February 21, 2019

Repligen to Report Fourth Quarter and Full Year 2018 Financial Results

GlobeNewswire February 15, 2019

Consolidated Research: 2019 Summary Expectations for Post, Westlake Chemical, Repligen, Weingarten Realty Investors, AptarGroup, and At Home Group — Fundamental Analysis, Key Performance Indications

GlobeNewswire January 23, 2019

Repligen to Present at 37th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 3, 2019

Repligen Reports Third Quarter 2018 Financial Results

GlobeNewswire November 1, 2018

Repligen to Report Third Quarter 2018 Financial Results

GlobeNewswire October 22, 2018

Recent Analysis Shows Repligen, SpartanNash, AZUL SA, Pacira Pharmaceuticals, Ichor, and Scorpio Tankers Market Influences — Renewed Outlook, Key Drivers of Growth

GlobeNewswire October 17, 2018

Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors

GlobeNewswire September 4, 2018

Recent Analysis Shows STMicroelectronics N.V, Jagged Peak Energy, Inovalon, AC Immune SA, Repligen, and RealNetworks Market Influences — Renewed Outlook, Key Drivers of Growth

GlobeNewswire August 22, 2018

Repligen Reports Second Quarter 2018 Financial Results

GlobeNewswire August 2, 2018

Repligen to Report Second Quarter 2018 Financial Results

GlobeNewswire July 19, 2018